- Report
- December 2021
- 100 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- May 2024
- 129 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- April 2024
- 115 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- March 2024
- 78 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Report
- October 2022
- 68 Pages
Global
- Report
- May 2024
- 90 Pages
United States
From €5211EUR$5,950USD£4,523GBP
- Report
- January 2024
- 120 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- August 2024
- 208 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- March 2024
- 163 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- May 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- February 2025
- 85 Pages
India
From €3065EUR$3,500USD£2,661GBP
- Report
- February 2025
- 85 Pages
India
From €3065EUR$3,500USD£2,661GBP
From €3065EUR$3,500USD£2,661GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3065EUR$3,500USD£2,661GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3065EUR$3,500USD£2,661GBP
- Report
- January 2025
- 140 Pages
Asia Pacific
From €3503EUR$4,000USD£3,041GBP
- Report
- October 2024
- 134 Pages
North America
From €3503EUR$4,000USD£3,041GBP
- Report
- July 2024
- 182 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- June 2024
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- February 2024
- 175 Pages
Global
From €3941EUR$4,500USD£3,421GBP

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more